The meta-analysis of pre-clinical data revealed that Gf usage upon cancer treatment significantly inhibited tumor growth, and, on the contrary, improved remission rates, and also increased CD4+ and CD8+ T cell percentages, as well as IL-2, IL-12, and TNF-α [420]. Here, CD4 is linked to neoplasm.